MEDICAL FACILITIES CORP (DR.CA) Stock Fundamental Analysis
Canada - TSX:DR - CA58457V5036 - Common Stock
14.48 CAD
-0.22 (-1.5%)
Overall DR gets a fundamental rating of 7 out of 10. We evaluated DR against 15 industry peers in the Health Care Providers & Services industry. DR scores excellent points on both the profitability and health parts. This is a solid base for a good stock. DR has a bad growth rate and is valued cheaply. With these ratings, DR could be worth investigating further for value investing!.
1. Profitability
1.1 Basic Checks
DR had positive earnings in the past year.
DR had a positive operating cash flow in the past year.
Of the past 5 years DR 4 years were profitable.
Each year in the past 5 years DR had a positive operating cash flow.
1.2 Ratios
With an excellent Return On Assets value of 29.34%, DR belongs to the best of the industry, outperforming 93.33% of the companies in the same industry.
DR's Return On Equity of 105.57% is amongst the best of the industry. DR outperforms 100.00% of its industry peers.
DR's Return On Invested Capital of 16.22% is amongst the best of the industry. DR outperforms 93.33% of its industry peers.
The Average Return On Invested Capital over the past 3 years for DR is significantly above the industry average of 7.83%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 29.34% | ||
| ROE | 105.57% | ||
| ROIC | 16.22% |
ROA(3y)8.42%
ROA(5y)6.13%
ROE(3y)25.39%
ROE(5y)18.93%
ROIC(3y)16.37%
ROIC(5y)14.6%
1.3 Margins
Looking at the Profit Margin, with a value of 28.90%, DR belongs to the top of the industry, outperforming 93.33% of the companies in the same industry.
DR's Profit Margin has improved in the last couple of years.
DR has a Operating Margin of 14.93%. This is amongst the best in the industry. DR outperforms 100.00% of its industry peers.
DR's Operating Margin has been stable in the last couple of years.
DR has a better Gross Margin (65.05%) than 93.33% of its industry peers.
In the last couple of years the Gross Margin of DR has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 14.93% | ||
| PM (TTM) | 28.9% | ||
| GM | 65.05% |
OM growth 3Y-0.97%
OM growth 5Y-1.3%
PM growth 3Y78.64%
PM growth 5Y55.2%
GM growth 3Y-0.53%
GM growth 5Y-0.42%
2. Health
2.1 Basic Checks
DR has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
Compared to 1 year ago, DR has less shares outstanding
The number of shares outstanding for DR has been reduced compared to 5 years ago.
Compared to 1 year ago, DR has an improved debt to assets ratio.
2.2 Solvency
Based on the Altman-Z score of 1.30, we must say that DR is in the distress zone and has some risk of bankruptcy.
DR has a Altman-Z score (1.30) which is comparable to the rest of the industry.
The Debt to FCF ratio of DR is 1.88, which is an excellent value as it means it would take DR, only 1.88 years of fcf income to pay off all of its debts.
With an excellent Debt to FCF ratio value of 1.88, DR belongs to the best of the industry, outperforming 93.33% of the companies in the same industry.
A Debt/Equity ratio of 1.25 is on the high side and indicates that DR has dependencies on debt financing.
The Debt to Equity ratio of DR (1.25) is comparable to the rest of the industry.
Even though the debt/equity ratio score it not favorable for DR, it has very limited outstanding debt, so we won't put too much weight on the DE evaluation.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.25 | ||
| Debt/FCF | 1.88 | ||
| Altman-Z | 1.3 |
ROIC/WACC1.89
WACC8.56%
2.3 Liquidity
DR has a Current Ratio of 1.58. This is a normal value and indicates that DR is financially healthy and should not expect problems in meeting its short term obligations.
DR has a better Current ratio (1.58) than 100.00% of its industry peers.
A Quick Ratio of 1.48 indicates that DR should not have too much problems paying its short term obligations.
With an excellent Quick ratio value of 1.48, DR belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.58 | ||
| Quick Ratio | 1.48 |
3. Growth
3.1 Past
DR shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 193.02%, which is quite impressive.
DR shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -37.06%.
Measured over the past years, DR shows a decrease in Revenue. The Revenue has been decreasing by -3.59% on average per year.
EPS 1Y (TTM)193.02%
EPS 3Y10.86%
EPS 5Y0%
EPS Q2Q%1100%
Revenue 1Y (TTM)-37.06%
Revenue growth 3Y-5.96%
Revenue growth 5Y-3.59%
Sales Q2Q%-24.84%
3.2 Future
DR is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 10.76% yearly.
The Revenue is expected to decrease by -7.10% on average over the next years.
EPS Next Y32.59%
EPS Next 2Y9.79%
EPS Next 3Y10.76%
EPS Next 5YN/A
Revenue Next Year-21.98%
Revenue Next 2Y-11.46%
Revenue Next 3Y-7.1%
Revenue Next 5YN/A
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
DR is valuated reasonably with a Price/Earnings ratio of 8.37.
Compared to the rest of the industry, the Price/Earnings ratio of DR indicates a rather cheap valuation: DR is cheaper than 93.33% of the companies listed in the same industry.
When comparing the Price/Earnings ratio of DR to the average of the S&P500 Index (27.20), we can say DR is valued rather cheaply.
DR is valuated reasonably with a Price/Forward Earnings ratio of 9.29.
100.00% of the companies in the same industry are more expensive than DR, based on the Price/Forward Earnings ratio.
DR's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 22.70.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 8.37 | ||
| Fwd PE | 9.29 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, DR is valued cheaply inside the industry as 100.00% of the companies are valued more expensively.
93.33% of the companies in the same industry are more expensive than DR, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 3.38 | ||
| EV/EBITDA | 4.27 |
4.3 Compensation for Growth
DR's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
DR has an outstanding profitability rating, which may justify a higher PE ratio.
PEG (NY)0.26
PEG (5Y)N/A
EPS Next 2Y9.79%
EPS Next 3Y10.76%
5. Dividend
5.1 Amount
With a Yearly Dividend Yield of 2.44%, DR has a reasonable but not impressive dividend return.
Compared to an average industry Dividend Yield of 3.33, DR pays a bit more dividend than its industry peers.
Compared to an average S&P500 Dividend Yield of 2.38, DR has a dividend comparable with the average S&P500 company.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.44% |
5.2 History
The dividend of DR decreases each year by -19.91%.
DR has been paying a dividend for at least 10 years, so it has a reliable track record.
DR has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)-19.91%
Div Incr Years1
Div Non Decr Years4
5.3 Sustainability
7.21% of the earnings are spent on dividend by DR. This is a low number and sustainable payout ratio.
DP7.21%
EPS Next 2Y9.79%
EPS Next 3Y10.76%
TSX:DR (9/17/2025, 7:00:00 PM)
14.48
-0.22 (-1.5%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners12.28%
Inst Owner ChangeN/A
Ins Owners0%
Ins Owner ChangeN/A
Market Cap268.02M
Analysts42.22
Price Target16.58 (14.5%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.44% |
Yearly Dividend0.35
Dividend Growth(5Y)-19.91%
DP7.21%
Div Incr Years1
Div Non Decr Years4
Ex-Date
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-16.26%
Min EPS beat(2)-24.98%
Max EPS beat(2)-7.54%
EPS beat(4)1
Avg EPS beat(4)-8.64%
Min EPS beat(4)-41.75%
Max EPS beat(4)39.71%
EPS beat(8)2
Avg EPS beat(8)-39.68%
EPS beat(12)4
Avg EPS beat(12)4.47%
EPS beat(16)6
Avg EPS beat(16)-104.58%
Revenue beat(2)0
Avg Revenue beat(2)-4.32%
Min Revenue beat(2)-4.5%
Max Revenue beat(2)-4.13%
Revenue beat(4)0
Avg Revenue beat(4)-8.01%
Min Revenue beat(4)-18.84%
Max Revenue beat(4)-4.13%
Revenue beat(8)2
Avg Revenue beat(8)-4.04%
Revenue beat(12)3
Avg Revenue beat(12)-2.78%
Revenue beat(16)4
Avg Revenue beat(16)-2.75%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)N/A
EPS NY rev (1m)50.31%
EPS NY rev (3m)50.31%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.54%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 8.37 | ||
| Fwd PE | 9.29 | ||
| P/S | 0.7 | ||
| P/FCF | 3.38 | ||
| P/OCF | 3.19 | ||
| P/B | 2.56 | ||
| P/tB | N/A | ||
| EV/EBITDA | 4.27 |
EPS(TTM)1.73
EY11.95%
EPS(NY)1.56
Fwd EY10.76%
FCF(TTM)4.28
FCFY29.55%
OCF(TTM)4.55
OCFY31.39%
SpS20.68
BVpS5.66
TBVpS-1.59
PEG (NY)0.26
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 29.34% | ||
| ROE | 105.57% | ||
| ROCE | 19.63% | ||
| ROIC | 16.22% | ||
| ROICexc | 21.11% | ||
| ROICexgc | 52.76% | ||
| OM | 14.93% | ||
| PM (TTM) | 28.9% | ||
| GM | 65.05% | ||
| FCFM | 20.69% |
ROA(3y)8.42%
ROA(5y)6.13%
ROE(3y)25.39%
ROE(5y)18.93%
ROIC(3y)16.37%
ROIC(5y)14.6%
ROICexc(3y)21.7%
ROICexc(5y)18.79%
ROICexgc(3y)53.59%
ROICexgc(5y)43.79%
ROCE(3y)19.81%
ROCE(5y)17.76%
ROICexcg growth 3Y35.06%
ROICexcg growth 5Y23.36%
ROICexc growth 3Y18.42%
ROICexc growth 5Y13.1%
OM growth 3Y-0.97%
OM growth 5Y-1.3%
PM growth 3Y78.64%
PM growth 5Y55.2%
GM growth 3Y-0.53%
GM growth 5Y-0.42%
F-Score6
Asset Turnover1.02
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.25 | ||
| Debt/FCF | 1.88 | ||
| Debt/EBITDA | 1.6 | ||
| Cap/Depr | 20.05% | ||
| Cap/Sales | 1.29% | ||
| Interest Coverage | 6.5 | ||
| Cash Conversion | 102.93% | ||
| Profit Quality | 71.58% | ||
| Current Ratio | 1.58 | ||
| Quick Ratio | 1.48 | ||
| Altman-Z | 1.3 |
F-Score6
WACC8.56%
ROIC/WACC1.89
Cap/Depr(3y)47.79%
Cap/Depr(5y)40.36%
Cap/Sales(3y)2.81%
Cap/Sales(5y)2.52%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)193.02%
EPS 3Y10.86%
EPS 5Y0%
EPS Q2Q%1100%
EPS Next Y32.59%
EPS Next 2Y9.79%
EPS Next 3Y10.76%
EPS Next 5YN/A
Revenue 1Y (TTM)-37.06%
Revenue growth 3Y-5.96%
Revenue growth 5Y-3.59%
Sales Q2Q%-24.84%
Revenue Next Year-21.98%
Revenue Next 2Y-11.46%
Revenue Next 3Y-7.1%
Revenue Next 5YN/A
EBIT growth 1Y-43.39%
EBIT growth 3Y-6.86%
EBIT growth 5Y-4.85%
EBIT Next Year-3.27%
EBIT Next 3Y2.22%
EBIT Next 5YN/A
FCF growth 1Y-0.32%
FCF growth 3Y4.28%
FCF growth 5Y3.38%
OCF growth 1Y-10.39%
OCF growth 3Y3.26%
OCF growth 5Y1.55%